Risk factors
MetaVia (MTVA) risk factors
Item 1A of every MetaVia Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors60 risks6 new9 dropped9 reworded
MetaVia faces heavy concentration risk with Dong-A ST and Dong-A Holdings controlling 35 percent of voting rights.
Filed Mar 26, 2026 - FY2024 10-K risk factors63 risks
Operating with no revenue and relying on cash into the third quarter of 2025. Licensing and relying exclusively on Dong-A for DA-1241 and DA-1726 development and manufacturing. Facing intense competition and public scrutiny in obesity and T2DM treatments.
Filed Mar 20, 2025